Skip to main content
. 2019 Jun 21;6:135. doi: 10.3389/fmed.2019.00135

Table 5.

Treatment outcomes.

Outcomes N/total (%)
Successful outcomes 338/375 (90.1)
Successful (overall PTB+EPTB) 338/375 (90.1)
Successful outcomes in culture or PCR positive PTB 165/183 (92.2)
Cured only PTB culture and/or PCR positive 106/183 (59.9)
Completed without bacteriological confirmation (PTB) 59/183 (32.2)
Successful outcomes in EPTB (completed) 95/103 (90.2)
Successful outcomes in AS (all included) 79/89 (88.8)
Successful outcomes in AS follow at DAT 60/67 (89.6)
Successful outcomes (PTB+EPTB) in Swiss patients 76/87 (87.3)
Unsuccessful Outcomes 19/375 (5.1)
Lost to follow-up 7/375 (1.8)
Failure 0/375 (0)
Deaths 12/375 (3.2)
Causes of death
Deaths due to TB 12/6 (50)
Deaths due to causes other than TB (comorbidities) 12/6 (50)
Deaths in Swiss patients 12/10 (83.3)
Death in foreign patients 10/2 (16.7)
List of comorbidities
Chronic Obstructive Pulmonary Disease 6/1 (16.6)
Heart failure 6/1 (16.6)
Immunosuppression/HIV 6/1 (16.6)
Immunosuppression /Anti-TNF therapy 6/1 (16.6)
Malignancy 6/2 (33.6)
Potentially unsuccessful outcomes 18/375 (4.8)
Transfer-out without knowledge of outcome 18/375 (4.8)

Tt, Treatment; TB, tuberculosis; P, pulmonary; EP, extra-pulmonary; AS, Asylum seekers.